Shangqi D. Yang
Guangzhou, 510632, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
Clinicopathological and molecular genetic characteristics of multifocal micronodular pneumocyte hyperplasia (MMPH)
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: December 08, 2025
Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.
Journal: Experimental and therapeutic medicine
Published: March 13, 2024
Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 03, 2023
Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: May 15, 2023
Targeting VCP potentiates immune checkpoint therapy for colorectal cancer.
Journal: Cell reports
Published: January 11, 2023
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma.
Journal: Nature communications
Published: November 01, 2022
GLIDR promotes the aggressiveness progression of prostate cancer cells by sponging miR-128-3p.
Journal: Pathology, research and practice
Published: September 26, 2022
HOXA1 promotes proliferation and metastasis of bladder cancer by enhancing SMAD3 transcription.
Journal: Pathology, research and practice
Published: June 04, 2022
Epstein-Barr virus infection-related post-transplant lymphoproliferative disorders in transplanted lung: a clinicopathological analysis
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: April 29, 2021
FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer.
Journal: Cell death & disease
Published: January 28, 2021
Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro.
Journal: Frontiers in molecular biosciences
Published: December 26, 2020
MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
Journal: European review for medical and pharmacological sciences
Published: July 25, 2020
Last Updated: 09/26/2026